Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine/artesunate with or without praziquantel for uncomplicated urogenital schistosomiasis in Gabonese children and adolescents
PACTR202402599048090Phase 2Unknown
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pyronaridine, artesunate and praziquantel in schistosomiasis haematobium (2 arms), sponsored by Bernhard Nocht Institute for Tropical Medicine. Status: unknown.
02
Drugs
pyronaridineartesunatepraziquantel
03
Conditions
schistosomiasis haematobium
Beyond the preview
Go deeper on PACTR202402599048090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202402599048090.